Development and validation of the lung donor (LUNDON) acceptability score for pulmonary transplantation [0.03%]
肺移植供体接受度评分（LUNDON）的制定与验证
Brendan T Heiden,Zhizhou Yang,Yun Zhu Bai et al.
Brendan T Heiden et al.
There is a chronic shortage of donor lungs for pulmonary transplantation due, in part, to low lung utilization rates in the United States. We performed a retrospective cohort study using data from the Scientific Registry of Transplant Recip...
Incidence of and risk factors for influenza-associated hospital encounters in pediatric solid organ transplant recipients [0.03%]
儿童实体器官移植受者流感相关住院事件的发病率及危险因素分析
Zaid Haddadin,Andrew J Spieker,Justin Z Amarin et al.
Zaid Haddadin et al.
Few studies have defined the incidence of and risk factors for influenza infection in pediatric solid organ transplant (SOT) recipients. We used a linkage between the Pediatric Health Information System and the Scientific Registry of Transp...
Use of tecovirimat for the treatment of mpox infection in a kidney transplant recipient [0.03%]
特考韦玛尔治疗肾移植受者的猴痘病毒感染病例报告
Sophie Caillard,Noelle Cognard,Peggy Perrin et al.
Sophie Caillard et al.
Uncovering new potentials: Screening for donor infectious disease serologies in less than 1 hour [0.03%]
揭秘新潜能：
Sam Ho,Amber Carriker,Kristin Sieg et al.
Sam Ho et al.
Increasing liver organ acquisition fees and the risk of a tragedy of the commons [0.03%]
不断上升的肝脏获取费用及公共资源悲剧的风险
Anji Wall,Giuliano Testa
Anji Wall
Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect [0.03%]
对题为“突破感染风险：免疫时间偏倚效应”的来信的回复
Ayman Al Jurdi,Leela Morena,Leonardo V Riella
Ayman Al Jurdi
Yashutosh Joshi,Peter Macdonald
Yashutosh Joshi
Anti-HLA antibodies in recipients of CD19 versus BCMA-targeted CAR T-cell therapy [0.03%]
CD19与BCMA靶向CAR-T细胞治疗受者中的抗HLA抗体
Joshua A Hill,Erika S Kiem,Atif Bhatti et al.
Joshua A Hill et al.
Antibodies against foreign human leukocyte antigen (HLA) molecules are barriers to successful organ transplantation. B cell-depleting treatments are used to reduce anti-HLA antibodies but have limited efficacy. We hypothesized that the prim...
Coronavirus disease-19 mortality among solid organ transplant recipients in the United States during June and December 2020: Comparison of Organ Procurement and Transplantation Network and National Death Index data [0.03%]
美国固体器官移植受者2020年6月至2020年12月期间的冠状病毒疾病-19死亡率：分析器官获取与分配系统和国家死亡指数的数据
Karena D Volesky-Avellaneda,Jon M Miller,Ajay K Israni et al.
Karena D Volesky-Avellaneda et al.
Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling [0.03%]
补体抑制通过调节磷脂酰肌醇3-激酶信号减轻供者脑死亡诱导的肝脏损伤和移植后的继发性损伤
Chengjie Lin,Biao Lei,Chunqiang Dong et al.
Chengjie Lin et al.
Brain death (BD) donors are the primary source of donor organs for liver transplantation. However, the effects of BD on donor livers and outcomes after liver transplantation remain unclear. Here, we explored the role of complement and the t...